These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34595976)

  • 21. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients.
    Zhang ZL; Chen W; Li YH; Liu ZW; Luo JH; Lau W; Tan MH; Zhou FJ
    Chin J Cancer; 2011 Nov; 30(11):772-8. PubMed ID: 22035858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of long-term survival in patients with localized renal cell carcinoma: laparoscopic versus open radical nephrectomy.
    Luo JH; Zhou FJ; Xie D; Zhang ZL; Liao B; Zhao HW; Dai YP; Chen LW; Chen W
    World J Urol; 2010 Jun; 28(3):289-93. PubMed ID: 19916010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
    Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
    World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
    Xue W; Zhang Y; Wang H; Zhang Y; Hu X
    Front Immunol; 2021; 12():778746. PubMed ID: 34917092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncological outcome of surgical treatment in 336 patients with renal cell carcinoma.
    Zhang ZL; Li YH; Xiong YH; Hou GL; Yao K; Dong P; Liu ZW; Han H; Qin ZK; Zhou FJ
    Chin J Cancer; 2010 Dec; 29(12):995-9. PubMed ID: 21114919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leibovich score is the optimal clinico-pathological system associated with recurrence of non-metastatic clear cell renal cell carcinoma.
    Blackmur JP; Gaba F; Fernando D; Williams S; O'Donnell M; McNeill A; Stewart GD; Leung S; Laird A
    Urol Oncol; 2021 Jul; 39(7):438.e11-438.e21. PubMed ID: 34023196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of body mass index and other tumor and patient characteristics in non-metastatic renal cell carcinoma.
    Ahmedov V; Kizilay F; Cüreklibatir I
    Urol J; 2018 May; 15(3):96-103. PubMed ID: 29464679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvage surgery after energy ablation for renal masses.
    Karam JA; Wood CG; Compton ZR; Rao P; Vikram R; Ahrar K; Matin SF
    BJU Int; 2015 Jan; 115(1):74-80. PubMed ID: 24656119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy.
    Życzkowski M; Rajwa P; Gabrys E; Jakubowska K; Jantos E; Paradysz A
    Clin Genitourin Cancer; 2018 Jun; 16(3):e677-e683. PubMed ID: 29339043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
    Bradshaw AW; Autorino R; Simone G; Yang B; Uzzo RG; Porpiglia F; Capitanio U; Porter J; Bertolo R; Minervini A; Lau C; Jacobsohn K; Ashrafi A; Eun D; Mottrie A; White WM; Schips L; Challacombe BJ; De Cobelli O; Mir CM; Veccia A; Larcher A; Kutikov A; Aron M; Dasgupta P; Montorsi F; Gill IS; Sundaram CP; Kaouk J; Derweesh IH
    BJU Int; 2020 Jul; 126(1):114-123. PubMed ID: 32232920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database.
    Liu F; Wang L; Meagher MF; Afari J; Saitta C; Dhanji S; Ghassemzadeh S; Shah A; Puri D; Nguyen MV; Hakimi K; Schmeusser B; Greenwald R; Medline A; Kamal F; Ali A; Fukuda S; Kobayashi M; Chen W; Fan B; Aida Y; Maezawa Y; Asai S; Tanaka H; Patil D; Fujii Y; Master V; Derweesh IH
    Urol Oncol; 2024 Oct; 42(10):333.e21-333.e31. PubMed ID: 38926077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncological outcomes of patients with incidental pathological T3a stage small renal cell carcinoma after partial nephrectomy.
    Lee C; You D; Yoo S; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1651-7. PubMed ID: 27193144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.
    Lau WK; Blute ML; Weaver AL; Torres VE; Zincke H
    Mayo Clin Proc; 2000 Dec; 75(12):1236-42. PubMed ID: 11126830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overall mortality after radical nephrectomy in patients aged over 80 years with renal cancer: a retrospective study on preoperative prognostic factors.
    Brassart E; Lebdai S; Berger J; Traore S; Bernhard JC; Fardoun T; Muller G; Patard JJ; Azzouzi AR; Bigot P
    Int J Urol; 2012 Jul; 19(7):626-32. PubMed ID: 22458762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer.
    Blute ML; Zorn K; Grimes M; Shi F; Downs TM; Jarrard DF; Best SL; Richards K; Nakada SY; Abel EJ
    BJU Int; 2016 Sep; 118(3):399-407. PubMed ID: 26589741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution.
    Takagi T; Yoshida K; Wada A; Kondo T; Fukuda H; Ishihara H; Kobayashi H; Iizuka J; Okumi M; Ishida H; Nagashima Y; Tanabe K
    Int J Clin Oncol; 2020 May; 25(5):892-898. PubMed ID: 32048086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
    Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
    J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of delaying radical nephrectomy for stage II or higher renal cell carcinoma.
    Kim KH; You D; Jeong IG; Song C; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1561-7. PubMed ID: 22547152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.